Community-Based Delivery and Administration of SARS-CoV-2 Antigen Rapid Diagnostic Tests: An Operational Research Study in Marketplaces in Malawi and Zambia
The American Journal of Tropical Medicine and Hygiene · 2025
DOI: 10.4269/ajtmh.23-0785 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von Fiona Gambanga und 14 weiteren Autor:innen. Beteiligte Einrichtung: Clinton Health Access Initiative, Boston, Massachusetts. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Serological Testing, COVID-19 Testing. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To expand access to testing beyond public health facilities and to strengthen surveillance efforts for COVID-19, community testing using COVID-19 antigen-based rapid diagnostic tests (Ag-RDTs) was identified as a major area of focus in Malawi and Zambia. This research aimed to gather evidence on the feasibility and acceptability of community testing in marketplaces. A cross-sectional study with a mixed-methods design was conducted in marketplaces in Malawi and Zambia to understand operational considerations for the implementation of Ag-RDTs for SARS-CoV-2 in a community setting. Programmatic data were collected prospectively as individuals were tested from June to September 2022. COVID-19 testing was done using Abbott Panbio nasal swab test kits. Semi-qualitative questionnaires were administered to individuals who tested, healthcare workers, and site-based personnel. Data were collected electronically via the SurveyCTO platform and analyzed using STATA. In Malawi, 2,348 participants were tested, and in Zambia, 1,723 people were tested for COVID-19. In Zambia, participants were 46% female, with a median age of 28 years, whereas in Malawi, participants were 69% female, with a median age of 37 years. In Malawi, 78 positive cases were reported (3.3% positivity rate), and in Zambia 10 positive cases were reported (0.5% positivity rate). In Zambia, 99% of 300 participants and in Malawi, 92% of 1,158 testers found the market testing experience and sample collection acceptable. Community testing is a feasible and acceptable intervention to increase testing access in Malawi and Zambia, especially when coupled with community awareness campaigns and mobilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinton Health Access Initiative, Boston, Massachusetts.
- Ministry of Health, HTSS-Diagnostics, Lilongwe Central Region, Malawi.
- Ministry of Health, Laboratory Services, Lusaka, Zambia.
- FIND, Geneva, Switzerland.
Zitieren
APA
Gambanga, F., Nchimunya, L., Makondesa, J., Chavula, C., Mulenga, N., Mwenifumbo, T., Chitanda, F., Mtaula, J., Tsai, Y., Bitilinyu-Bangoh, J., Gunda, A., Shibemba, A., Choonga, P., Khan, S., & Peter, T. (2025). Community-Based Delivery and Administration of SARS-CoV-2 Antigen Rapid Diagnostic Tests: An Operational Research Study in Marketplaces in Malawi and Zambia. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0785
Vancouver
Gambanga F, Nchimunya L, Makondesa J, Chavula C, Mulenga N, Mwenifumbo T, et al. Community-Based Delivery and Administration of SARS-CoV-2 Antigen Rapid Diagnostic Tests: An Operational Research Study in Marketplaces in Malawi and Zambia. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.23-0785
BibTeX
@article{Gambanga2025,
author = {Gambanga, Fiona and Nchimunya, Lindiwe and Makondesa, Joseph and Chavula, Chancy and Mulenga, Namwaka and Mwenifumbo, Tamara and Chitanda, Francis and Mtaula, Jonathan and Tsai, Yucheng and Bitilinyu-Bangoh, Joseph and Gunda, Andrews and Shibemba, Aaron and Choonga, Powell and Khan, Shaukat and Peter, Trevor},
title = {Community-Based Delivery and Administration of SARS-CoV-2 Antigen Rapid Diagnostic Tests: An Operational Research Study in Marketplaces in Malawi and Zambia},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2025},
doi = {10.4269/ajtmh.23-0785}
}
EUVIMED